The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationInfectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationEmergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism
Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 727
Self-citationDenning, D. W., Riniotis, K., Dobrashian, R., & Sambatakou, H. (2003) · Clinical Infectious Diseases · doi:10.1086/376526 · Cited by 554
Self-citation46th Interscience Conference on Antimicrobial Agents and Chemotherapy
McConnell, J. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70621-1 · Cited by 541
Itraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 508
Self-citationMellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490
Self-citationBrüggemann, R. J. M., Alffenaar, J. C., Blijlevens, N. M. A., Billaud, E. M., Kosterink, J. G. W., Verweij, P. E., & Burger, D. M. (2009) · Clinical Infectious Diseases · doi:10.1086/598327 · Cited by 457
Self-citationPossible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles
Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423
Self-citation46th Interscience Conference on Antimicrobial Agents and Chemotherapy
Vila, J., & Bonomo, R. A. (2007) · Future Microbiology · doi:10.2217/17460913.2.1.9 · Cited by 420
Aspergillus lentulus sp. nov., a New Sibling Species of A. fumigatus
Balajee, S. A., Gribskov, J. L., Hanley, E., Nickle, D., & Marr, K. A. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.3.625-632.2005 · Cited by 404
Multiple-Triazole–Resistant Aspergillosis
Verweij, P. E., Mellado, E., & Melchers, W. J. G. (2007) · New England Journal of Medicine · doi:10.1056/nejmc061720 · Cited by 380
Self-citationInfections Due to Aspergillus terreus: A Multicenter Retrospective Analysis of 83 Cases
Steinbach, W. J., Benjamin, D. K., Kontoyiannis, D. P., Perfect, J. R., Lutsar, I., Marr, K. A., Lionakis, M. S., Torres, H. A., Jafri, H., & Walsh, T. J. (2004) · Clinical Infectious Diseases · doi:10.1086/421950 · Cited by 293
Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281
Xiao, L., Madison, V., Chau, A. S., Loebenberg, D., Palermo, R. E., & McNicholas, P. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.568-574.2004 · Cited by 267
Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., & Perlin, D. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1719-1726.2003 · Cited by 258
Walsh, T. J., Petraitis, V., Petraitiene, R., Field‐Ridley, A., Sutton, D., Ghannoum, M., Sein, T., Schaufele, R., Peter, J., Bacher, J., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377210 · Cited by 253
Denning, D. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.401 · Cited by 235
Self-citationMellado, E., Garcia-Effron, G., Alcazar-Fuoli, L., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2747-2750.2004 · Cited by 210
Multi-azole resistance in Aspergillus fumigatus
Howard, S. J., Webster, I., Moore, C. B., Gardiner, R. E., Park, S., Perlin, D. S., & Denning, D. W. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.017 · Cited by 203
Self-citationSlaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W. (2002) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00016-6 · Cited by 202
Self-citationChen, J., Li, H., Li, R., Bu, D., & Wan, Z. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh507 · Cited by 198
Mann, P. A., Parmegiani, R. M., Wei, S.-Q., Mendrick, C. A., Li, X., Loebenberg, D., DiDomenico, B., Hare, R. S., Walker, S. S., & McNicholas, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.577-581.2003 · Cited by 189
Cuenca-Estrella, M., Moore, C. B., Barchiesi, F., Bille, J., Chryssanthou, E., Denning, D. W., Donnelly, J. P., Dromer, F., Dupont, B., Rex, J. H., et al. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00592.x · Cited by 160
Self-citationAcquired itraconazole resistance in Aspergillus fumigatus
Dannaoui, É. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.333 · Cited by 144
Rodríguez-Tudela, J. L., Almirante, B., Rodríguez-Pardo, D., Laguna, F., Donnelly, J. P., Mouton, J. W., Pahissa, A., & Cuenca-Estrella, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-07 · Cited by 137
Varga, J., Houbraken, J. A. M. P., van der Lee, H. A. L., Verweij, P. E., & Samson, R. A. (2008) · Eukaryotic Cell · doi:10.1128/ec.00425-07 · Cited by 128
Self-citationHodiamont, C. J., Dolman, K. M., ten Berge, I. J. M., Melchers, W. J. G., Verweij, P. E., & Pajkrt, D. (2008) · Medical Mycology · doi:10.1080/13693780802545600 · Cited by 124
Self-citationRodriguez-Tudela, J. L., Jp, D., Arendrup, M., Arıkan, S., Barchiesi, F., Billé, J., Chryssanthou, E., Cuenca‐Estrella, M., Dannaoui, É., Denning, D. W., et al. (2009) · Research Explorer (The University of Manchester) · Cited by 122
Self-citationAzole Cross-Resistance in Aspergillus fumigatus
Mosquera, J., & Denning, D. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.556-557.2002 · Cited by 121
Self-citationPfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00535-08 · Cited by 119
Arendrup, M. C., Perkhofer, S., Howard, S. J., García‐Effrón, G., Aimanianda, V., Perlin, D. S., & Lass‐Flörl, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00190-08 · Cited by 116
Self-citationMavridou, E., Brüggemann, R. J. M., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00931-09 · Cited by 112
Self-citationOakley, K. L., Morrissey, G., & Denning, D. W. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1504 · Cited by 109
Self-citationChryssanthou, E. (1997) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549709011864 · Cited by 105
Johnson, E. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.1.85 · Cited by 105
Multidrug Resistance inAspergillus fumigatus
Warris, A., Weemaes, C. M. R., & Verweij, P. E. (2002) · New England Journal of Medicine · doi:10.1056/nejm200212263472618 · Cited by 86
Self-citationAzole‐Resistant Central Nervous System Aspergillosis
van der Linden, J. W. M., Jansen, R. R., Bresters, D., Visser, C. E., Geerlings, S. E., Kuijper, E. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597465 · Cited by 85
Self-citationAspergillus nidulans is frequently resistant to amphotericin B
Kontoyiannis, D. P., Lewis, R. E., May, G. S., Osherov, N., & Rinaldi, M. G. (2002) · Mycoses · doi:10.1046/j.1439-0507.2002.00797.x · Cited by 75
Manavathu, E. K., Cutright, J. L., & Chandrasekar, P. H. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.3.858-861.1999 · Cited by 71
Mosquera, J., Warn, P. A., Morrissey, J., Moore, C. B., Gil‐Lamaignere, C., & Denning, D. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1456-1462.2001 · Cited by 68
Self-citationCuenca‐Estrella, M., Arendrup, M. C., Chryssanthou, E., Dannaoui, É., Lass‐Flörl, C., Sandven, P., Velegraki, A., & Rodríguez-Tudela, J. L. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01790.x · Cited by 54
Hope, W. W., Warn, P. A., Sharp, J., Howard, S. J., Kasai, M., Louie, A., Walsh, T. J., Drusano, G. L., & Denning, D. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00369-06 · Cited by 49
Self-citationSusceptibility testing of pathogenic fungi with itraconazole: a process analysis of test variables
Rambali, B., Fernandez, J. A., Nuffel, L. V., Woestenborghs, F., Baert, L., Massart, D. L., & Odds, F. C. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.2.163 · Cited by 39
In vitro susceptibility‐testing in Aspergillus species
Lass‐Flörl, C., & Perkhofer, S. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01510.x · Cited by 29
Guinea, J., Recio, S., Peláez, T., Torres-Narbona, M., & Bouza, E. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00629-08 · Cited by 25
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationUllmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationAntifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationMechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Self-citation
Metadata
- Authors
- Verweij, P. E., Howard, S. J., Melchers, W. J. G., & Denning, D. W.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 12
- Issue
- 6
- Pages
- 141-147
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2166972217
- Cited by
- 260
- References
- 51
- FWCI
- 21.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.